Clinical Trial Update: First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm Trial [Phase 3]

View source ↗

Summary

A phase 3 single-center trial investigating first-line treatment for advanced non-squamous non-small-cell lung cancer without driver mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Advanced Non-squamous Non-Small-Cell Lung Cancer | Phase 3 | Status: UNKNOWN